Literature DB >> 882146

The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.

H Iven.   

Abstract

After i.v. infusion into mice (lasting 10 s) the time courses of ajmaline and quinidine concentrations in blood, heart, lung, liver, and brain were studied. The drugs were assayed by a spectrofluorophotometric procedure. Blood concentration data obtained were fitted graphically and calculations were performed in accordance with an open two compartment model. Blood kinetic data were very similar for both alkaloids. A rapid distribution phase with a t0.5alpha of 3.0 min for ajmaline and 2.5 min for quindine was followed by a disposition phase with a t0.5beta of 16 min for ajmaline and 20 min for quinidine. High tissue accumulation of both alkaloids was found in lung, liver, and heart and this is also reflected by the volume of distribution Vdbeta, which was 136 ml for ajmaline and 116 ml for quinidine (body weight of the mice = 31 g). With equilibrium dialysis a 62% binding of ajmaline and a 77% binding of quinidine to mouse blood constituents was found. Both drugs were highly metabolized since only 5% of a given dose was excreted unchanged in the urine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 882146     DOI: 10.1007/bf00510985

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT.

Authors:  H L CONN; R J LUCHI
Journal:  Am J Med       Date:  1964-11       Impact factor: 4.965

2.  Some quantitative aspects of the binding of quinidine and related quinoline compounds by human serum albumin.

Authors:  H L CONN; R J LUCHI
Journal:  J Clin Invest       Date:  1961-03       Impact factor: 14.808

3.  Quinidine: arterial, venous, coronary sinus and myocardial concentrations.

Authors:  L SCHERLIS; L F GONZALEZ; S P BESSMAN
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

4.  [Behavior of the serum level after intravenous injections of ajmaline].

Authors:  H KLEINSORGE; P GAIDA
Journal:  Klin Wochenschr       Date:  1962-02-01

5.  PHARMACOKINETICS In the rat of the hallucinogenic alkaloids harmine and harmaline.

Authors:  G Zetler; G Back; H Iven
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

7.  Accumulation of 14 C-imipramine in isolated perfused rat lungs.

Authors:  A F Junod
Journal:  J Pharmacol Exp Ther       Date:  1972-10       Impact factor: 4.030

8.  The metabolic fate of orally administered quinidine gluconate in humans.

Authors:  K H Palmer; B Martin; B Baggett; M E Wall
Journal:  Biochem Pharmacol       Date:  1969-08       Impact factor: 5.858

9.  Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs.

Authors:  T C Orton; M W Anderson; R D Pickett; T E Eling; J R Fouts
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

10.  Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.

Authors:  A Hayes; R G Cooper
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

View more
  10 in total

1.  Role of phosphatidylserine in the cellular and subcellular lung distribution of quinidine in rats.

Authors:  A Nishiura; T Murakami; Y Higashi; N Yata
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

2.  Pharmacokinetics and dromotropic activity of ajmaline in rats with hyperthyroidism.

Authors:  Y Hashimoto; M Yasuhara; A Kamiya; K Okumura; R Hori
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals.

Authors:  Y Sawada; M Hanano; Y Sugiyama; H Harashima; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1984-12

4.  Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.

Authors:  H Harashima; Y Sawada; Y Sugiyama; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1985-08

5.  Carrier-mediated uptake of clonidine in cultured human lung cells.

Authors:  Marc Le Vée; Elodie Jouan; Olivier Fardel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-19       Impact factor: 3.000

6.  Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.

Authors:  Yeamin Huh; David E Smith; Meihau Rose Feng
Journal:  Xenobiotica       Date:  2011-09-05       Impact factor: 1.908

7.  Kinetics of ajmaline disposition and pharmacologic response in beagle dogs.

Authors:  M Yasuhara; Y Hashimoto; K Okumura; R Hori; T Sakurai; C Kawai
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

8.  Ajmaline test in a patient with chronic renal failure. A pharmacokinetic and pharmacodynamic study.

Authors:  R Padrini; L Compostella; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

9.  Pharmacokinetics and electrophysiological effects of intravenous ajmaline.

Authors:  R Padrini; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

10.  Regional myocardial ajmaline concentration and antiarrhythmic activity for ischaemia- and reperfusion-induced arrhythmias in rats.

Authors:  K Okumura; Y Hashimoto; M Yasuhara; R Hori
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.